Impact BioMedical, Inc.

IBOAMEX • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
0.47 USD
↘ 0.01 (1.05%)AT CLOSE (11:59 AM EDT)
0.49
↗ 0.02 (3.48%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
0.49
↗ 0.02 (3.48%)
🔴Market: CLOSED

Impact BioMedical, Inc. (IBO) trades at $0.47 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, IBO is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 26, 2026.

Open?$0.47
High?$0.49
Low?$0.46
Prev. Close?$0.48
Volume?27.4K
Avg. Volume?69.3K
VWAP?$0.47
Rel. Volume?0.39x
Bid / Ask
Bid?$0.44 × 2.5K
Ask?$0.52 × 3.0K
Spread?$0.08
Midpoint?$0.48
Valuation & Ratios
Market Cap?50.7M
Shares Out?107.8M
Float?11.7M
Float %?10.9%
P/E Ratio?N/A
P/B Ratio?4.42
EPS?-$0.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Themes
Biotech - Drug Development›Neuroscience & CNSHealthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Infectious Disease & Vaccines
Employees
8
Market Cap
51.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.impactbiomedinc.com
Listed
2024-09-16
Address
1400 BROADFIELD BLVD.
HOUSTON, TX 77084
Phone: 585 232 1500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
73
Piotroski F-Score?0/9Weak
Altman Z-Score?7.40Safe
Confidence?36%Very Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?5.30%Elevated
Short Interest?621.0K
Days to Cover?6.4
Free Float11.7M
Avg Daily Volume96.6K
Settlement Date2026-06-15
Financial Health
Current Ratio?0.22Weak
Quick Ratio?0.19Weak
Cash Ratio?0.01Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
41
4.42FAIR▾
P/S?
Peers
100
S&P
3
1,299.38HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-11.5CHEAP▾
EV/Sales?
Peers
100
S&P
3
1,298.87HIGH▾
Returns & Efficiency
ROE?
S&P
3
-112.2%WEAK▾
ROA?
S&P
3
-75.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$50.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist